Global Dry Eye Syndrome Treatment market is expected to grow from US$ 5998 million in 2025 to US$ 7887 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.

Global Dry Eye Syndrome Treatment Market Size and Outlook 2025-31

The global Dry Eye Syndrome Treatment market size is predicted to grow from US$ 5998 million in 2025 to US$ 7887 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment. In this report, we mainly study the drugs and eye drops for dry eye. The Dry Eye Syndrome market is driven by the rising prevalence of dry eye conditions globally, fueled by aging populations, increased screen time, and lifestyle-related factors. The widespread use of digital devices has significantly contributed to eye strain and reduced blink rates, leading to a surge in dry eye cases, especially among younger demographics. Additionally, growing awareness of ocular health and improved diagnosis through advanced diagnostic tools have increased patient identification and treatment rates. The introduction of innovative therapies, including anti-inflammatory eye drops, tear-stimulating drugs, and device-based treatments, is also expanding the market landscape. Despite growing demand, the Dry Eye Syndrome market faces several challenges, including underdiagnosis, variable symptoms, and limited long-term treatment efficacy. Many patients remain undiagnosed due to the overlap of symptoms with other ocular conditions and the subjective nature of the disease. Current treatments often offer only temporary relief rather than a cure, leading to poor adherence and patient dissatisfaction. Moreover, the development of new therapies is hindered by the complex pathophysiology of the condition, which involves both aqueous and evaporative components. Addressing these challenges requires improved diagnostic criteria, personalized treatment approaches, and increased investment in research and clinical trials. Infinity Market Research newest research report, the Dry Eye Syndrome Treatment Industry Forecast looks at past sales and reviews total world Dry Eye Syndrome Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Dry Eye Syndrome Treatment sales for 2025 through 2031. With Dry Eye Syndrome Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Eye Syndrome Treatment industry. This Insight Report provides a comprehensive analysis of the global Dry Eye Syndrome Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Eye Syndrome Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Dry Eye Syndrome Treatment market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Eye Syndrome Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Eye Syndrome Treatment. This report presents a comprehensive overview, market shares, and growth opportunities of Dry Eye Syndrome Treatment market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Liquid Drops &nbsp;&nbsp;&nbsp; Gel &nbsp;&nbsp;&nbsp; Liquid Wipes &nbsp;&nbsp;&nbsp; Eye Ointment &nbsp;&nbsp;&nbsp; Other Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic &nbsp;&nbsp;&nbsp; Home Care This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; AbbVie &nbsp;&nbsp;&nbsp; Alcon &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Santen Pharma &nbsp;&nbsp;&nbsp; Johnson & Johnson &nbsp;&nbsp;&nbsp; Bausch & Lomb &nbsp;&nbsp;&nbsp; Thea pharmaceuticals &nbsp;&nbsp;&nbsp; URSAPHARM &nbsp;&nbsp;&nbsp; SIMILASAN &nbsp;&nbsp;&nbsp; Akorn &nbsp;&nbsp;&nbsp; United Laboratories &nbsp;&nbsp;&nbsp; Sun Pharmaceutical &nbsp;&nbsp;&nbsp; Jianfeng Group &nbsp;&nbsp;&nbsp; OmniVision Pharma &nbsp;&nbsp;&nbsp; Rohto &nbsp;&nbsp;&nbsp; Prestige Consumer Healthcare &nbsp;&nbsp;&nbsp; LION &nbsp;&nbsp;&nbsp; Kenvue (VISINE) Key Questions Addressed in this Report What is the 10-year outlook for the global Dry Eye Syndrome Treatment market? What factors are driving Dry Eye Syndrome Treatment market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Dry Eye Syndrome Treatment market opportunities vary by end market size? How does Dry Eye Syndrome Treatment break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Dry Eye Syndrome Treatment Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Dry Eye Syndrome Treatment by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Dry Eye Syndrome Treatment by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Dry Eye Syndrome Treatment Segment by Type &nbsp;2.2.1 Liquid Drops &nbsp;2.2.2 Gel &nbsp;2.2.3 Liquid Wipes &nbsp;2.2.4 Eye Ointment &nbsp;2.2.5 Other &nbsp;2.3 Dry Eye Syndrome Treatment Sales by Type &nbsp;2.3.1 Global Dry Eye Syndrome Treatment Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Dry Eye Syndrome Treatment Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Dry Eye Syndrome Treatment Sale Price by Type (2020-2025) &nbsp;2.4 Dry Eye Syndrome Treatment Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinic &nbsp;2.4.3 Home Care &nbsp;2.5 Dry Eye Syndrome Treatment Sales by Application &nbsp;2.5.1 Global Dry Eye Syndrome Treatment Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Dry Eye Syndrome Treatment Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Dry Eye Syndrome Treatment Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Dry Eye Syndrome Treatment Breakdown Data by Company &nbsp;3.1.1 Global Dry Eye Syndrome Treatment Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Dry Eye Syndrome Treatment Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Dry Eye Syndrome Treatment Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Dry Eye Syndrome Treatment Revenue by Company (2020-2025) &nbsp;3.2.2 Global Dry Eye Syndrome Treatment Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Dry Eye Syndrome Treatment Sale Price by Company &nbsp;3.4 Key Manufacturers Dry Eye Syndrome Treatment Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Dry Eye Syndrome Treatment Product Location Distribution &nbsp;3.4.2 Players Dry Eye Syndrome Treatment Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Dry Eye Syndrome Treatment by Geographic Region &nbsp;4.1 World Historic Dry Eye Syndrome Treatment Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Dry Eye Syndrome Treatment Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Dry Eye Syndrome Treatment Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Dry Eye Syndrome Treatment Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Dry Eye Syndrome Treatment Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Dry Eye Syndrome Treatment Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Dry Eye Syndrome Treatment Sales Growth &nbsp;4.4 APAC Dry Eye Syndrome Treatment Sales Growth &nbsp;4.5 Europe Dry Eye Syndrome Treatment Sales Growth &nbsp;4.6 Middle East & Africa Dry Eye Syndrome Treatment Sales Growth 5 Americas &nbsp;5.1 Americas Dry Eye Syndrome Treatment Sales by Country &nbsp;5.1.1 Americas Dry Eye Syndrome Treatment Sales by Country (2020-2025) &nbsp;5.1.2 Americas Dry Eye Syndrome Treatment Revenue by Country (2020-2025) &nbsp;5.2 Americas Dry Eye Syndrome Treatment Sales by Type (2020-2025) &nbsp;5.3 Americas Dry Eye Syndrome Treatment Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Dry Eye Syndrome Treatment Sales by Region &nbsp;6.1.1 APAC Dry Eye Syndrome Treatment Sales by Region (2020-2025) &nbsp;6.1.2 APAC Dry Eye Syndrome Treatment Revenue by Region (2020-2025) &nbsp;6.2 APAC Dry Eye Syndrome Treatment Sales by Type (2020-2025) &nbsp;6.3 APAC Dry Eye Syndrome Treatment Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Dry Eye Syndrome Treatment by Country &nbsp;7.1.1 Europe Dry Eye Syndrome Treatment Sales by Country (2020-2025) &nbsp;7.1.2 Europe Dry Eye Syndrome Treatment Revenue by Country (2020-2025) &nbsp;7.2 Europe Dry Eye Syndrome Treatment Sales by Type (2020-2025) &nbsp;7.3 Europe Dry Eye Syndrome Treatment Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Dry Eye Syndrome Treatment by Country &nbsp;8.1.1 Middle East & Africa Dry Eye Syndrome Treatment Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Dry Eye Syndrome Treatment Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Dry Eye Syndrome Treatment Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Dry Eye Syndrome Treatment Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Dry Eye Syndrome Treatment &nbsp;10.3 Manufacturing Process Analysis of Dry Eye Syndrome Treatment &nbsp;10.4 Industry Chain Structure of Dry Eye Syndrome Treatment 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Dry Eye Syndrome Treatment Distributors &nbsp;11.3 Dry Eye Syndrome Treatment Customer 12 World Forecast Review for Dry Eye Syndrome Treatment by Geographic Region &nbsp;12.1 Global Dry Eye Syndrome Treatment Market Size Forecast by Region &nbsp;12.1.1 Global Dry Eye Syndrome Treatment Forecast by Region (2026-2031) &nbsp;12.1.2 Global Dry Eye Syndrome Treatment Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Dry Eye Syndrome Treatment Forecast by Type (2026-2031) &nbsp;12.7 Global Dry Eye Syndrome Treatment Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 AbbVie &nbsp;13.1.1 AbbVie Company Information &nbsp;13.1.2 AbbVie Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.1.3 AbbVie Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 AbbVie Main Business Overview &nbsp;13.1.5 AbbVie Latest Developments &nbsp;13.2 Alcon &nbsp;13.2.1 Alcon Company Information &nbsp;13.2.2 Alcon Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.2.3 Alcon Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Alcon Main Business Overview &nbsp;13.2.5 Alcon Latest Developments &nbsp;13.3 Novartis &nbsp;13.3.1 Novartis Company Information &nbsp;13.3.2 Novartis Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.3.3 Novartis Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Novartis Main Business Overview &nbsp;13.3.5 Novartis Latest Developments &nbsp;13.4 Santen Pharma &nbsp;13.4.1 Santen Pharma Company Information &nbsp;13.4.2 Santen Pharma Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.4.3 Santen Pharma Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Santen Pharma Main Business Overview &nbsp;13.4.5 Santen Pharma Latest Developments &nbsp;13.5 Johnson & Johnson &nbsp;13.5.1 Johnson & Johnson Company Information &nbsp;13.5.2 Johnson & Johnson Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.5.3 Johnson & Johnson Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Johnson & Johnson Main Business Overview &nbsp;13.5.5 Johnson & Johnson Latest Developments &nbsp;13.6 Bausch & Lomb &nbsp;13.6.1 Bausch & Lomb Company Information &nbsp;13.6.2 Bausch & Lomb Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.6.3 Bausch & Lomb Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Bausch & Lomb Main Business Overview &nbsp;13.6.5 Bausch & Lomb Latest Developments &nbsp;13.7 Thea pharmaceuticals &nbsp;13.7.1 Thea pharmaceuticals Company Information &nbsp;13.7.2 Thea pharmaceuticals Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.7.3 Thea pharmaceuticals Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Thea pharmaceuticals Main Business Overview &nbsp;13.7.5 Thea pharmaceuticals Latest Developments &nbsp;13.8 URSAPHARM &nbsp;13.8.1 URSAPHARM Company Information &nbsp;13.8.2 URSAPHARM Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.8.3 URSAPHARM Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 URSAPHARM Main Business Overview &nbsp;13.8.5 URSAPHARM Latest Developments &nbsp;13.9 SIMILASAN &nbsp;13.9.1 SIMILASAN Company Information &nbsp;13.9.2 SIMILASAN Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.9.3 SIMILASAN Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 SIMILASAN Main Business Overview &nbsp;13.9.5 SIMILASAN Latest Developments &nbsp;13.10 Akorn &nbsp;13.10.1 Akorn Company Information &nbsp;13.10.2 Akorn Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.10.3 Akorn Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Akorn Main Business Overview &nbsp;13.10.5 Akorn Latest Developments &nbsp;13.11 United Laboratories &nbsp;13.11.1 United Laboratories Company Information &nbsp;13.11.2 United Laboratories Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.11.3 United Laboratories Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 United Laboratories Main Business Overview &nbsp;13.11.5 United Laboratories Latest Developments &nbsp;13.12 Sun Pharmaceutical &nbsp;13.12.1 Sun Pharmaceutical Company Information &nbsp;13.12.2 Sun Pharmaceutical Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.12.3 Sun Pharmaceutical Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Sun Pharmaceutical Main Business Overview &nbsp;13.12.5 Sun Pharmaceutical Latest Developments &nbsp;13.13 Jianfeng Group &nbsp;13.13.1 Jianfeng Group Company Information &nbsp;13.13.2 Jianfeng Group Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.13.3 Jianfeng Group Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Jianfeng Group Main Business Overview &nbsp;13.13.5 Jianfeng Group Latest Developments &nbsp;13.14 OmniVision Pharma &nbsp;13.14.1 OmniVision Pharma Company Information &nbsp;13.14.2 OmniVision Pharma Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.14.3 OmniVision Pharma Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 OmniVision Pharma Main Business Overview &nbsp;13.14.5 OmniVision Pharma Latest Developments &nbsp;13.15 Rohto &nbsp;13.15.1 Rohto Company Information &nbsp;13.15.2 Rohto Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.15.3 Rohto Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.15.4 Rohto Main Business Overview &nbsp;13.15.5 Rohto Latest Developments &nbsp;13.16 Prestige Consumer Healthcare &nbsp;13.16.1 Prestige Consumer Healthcare Company Information &nbsp;13.16.2 Prestige Consumer Healthcare Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.16.3 Prestige Consumer Healthcare Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.16.4 Prestige Consumer Healthcare Main Business Overview &nbsp;13.16.5 Prestige Consumer Healthcare Latest Developments &nbsp;13.17 LION &nbsp;13.17.1 LION Company Information &nbsp;13.17.2 LION Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.17.3 LION Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.17.4 LION Main Business Overview &nbsp;13.17.5 LION Latest Developments &nbsp;13.18 Kenvue (VISINE) &nbsp;13.18.1 Kenvue (VISINE) Company Information &nbsp;13.18.2 Kenvue (VISINE) Dry Eye Syndrome Treatment Product Portfolios and Specifications &nbsp;13.18.3 Kenvue (VISINE) Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.18.4 Kenvue (VISINE) Main Business Overview &nbsp;13.18.5 Kenvue (VISINE) Latest Developments 14 Research Findings and Conclusion

Report	Global Dry Eye Syndrome Treatment Market Growth 2025-2031
Selected License	Multi ID: LPI24744

Buyer Information

Order Summary